chr5-180312451-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005110.4(GFPT2):c.1525C>T(p.Arg509Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000254 in 1,595,700 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005110.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GFPT2 | NM_005110.4 | c.1525C>T | p.Arg509Cys | missense_variant | 15/19 | ENST00000253778.13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GFPT2 | ENST00000253778.13 | c.1525C>T | p.Arg509Cys | missense_variant | 15/19 | 1 | NM_005110.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000353 AC: 88AN: 249512Hom.: 0 AF XY: 0.000362 AC XY: 49AN XY: 135372
GnomAD4 exome AF: 0.000253 AC: 365AN: 1443498Hom.: 0 Cov.: 27 AF XY: 0.000254 AC XY: 183AN XY: 719358
GnomAD4 genome AF: 0.000269 AC: 41AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2022 | The c.1525C>T (p.R509C) alteration is located in exon 15 (coding exon 15) of the GFPT2 gene. This alteration results from a C to T substitution at nucleotide position 1525, causing the arginine (R) at amino acid position 509 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at